The TPM3‐NTRK1 rearrangement is a recurring event in colorectal carcinoma and is associated with tumor sensitivity to TRKA kinase inhibitionElena Ardini, Antonella Isacchi, Alessio Somaschini et al.|Molecular Oncology|2014Cited by 156
Abstract P2-15-14: Triple negative (TNBC) metastatic breast cancer (MBC) patients (pts): Is chemotherapy (CHT) choice influenced by adjuvant (adj) treatments? Results from the GIM-13 AMBRA studyGiorgio Mustacchi, Alessandra Beano, Alessandra Fabi et al.|Cancer Research|2020Cited by 0
Abstract P5-07-10: Progression-free survival (PFS) and overall survival (OS) in HER2-ve advanced breast cancer (ABC) patients (pts) according to the molecular subtype in the era of modern agents. Results from the GIM-13 AMBRA studyMarina Elena Cazzaniga, Sabino De Placido, Alessia D’Alonzo et al.|Cancer Research|2020Cited by 0